|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
|
|
gptkbp:ATCCode
|
gptkb:H01BA02
|
|
gptkbp:brand
|
gptkb:Minirin
gptkb:DDAVP
gptkb:Stimate
|
|
gptkbp:CASNumber
|
16679-58-6
|
|
gptkbp:chemicalClass
|
peptide
|
|
gptkbp:contraindication
|
hyponatremia
moderate to severe kidney disease
|
|
gptkbp:discoveredBy
|
gptkb:Janusz_W._Wada
|
|
gptkbp:discoveredIn
|
1977
|
|
gptkbp:eliminationHalfLife
|
2–3 hours
|
|
gptkbp:excretion
|
gptkb:kidney
|
|
gptkbp:form
|
acetate salt
|
|
gptkbp:hasMolecularFormula
|
C46H64N14O12S2
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Desmopressin
|
|
gptkbp:KEGGID
|
gptkb:D07714
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
vasopressin receptor agonist
|
|
gptkbp:MeSH_ID
|
D003882
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
1069.22 g/mol
|
|
gptkbp:origin
|
synthetic
|
|
gptkbp:pregnancyCategory
|
B (US)
B3 (Australia)
|
|
gptkbp:PubChem_CID
|
CHEMBL1201207
10482154
16130919
DB00035
|
|
gptkbp:relatedTo
|
gptkb:vasopressin
|
|
gptkbp:riskFactor
|
water intoxication
seizures (from hyponatremia)
|
|
gptkbp:routeOfAdministration
|
oral
intravenous
intranasal
sublingual
|
|
gptkbp:sideEffect
|
nausea
abdominal pain
headache
hyponatremia
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:UNII
|
Q528I9PVM9
|
|
gptkbp:usedFor
|
gptkb:von_Willebrand_disease
gptkb:hemophilia_A
gptkb:diabetes_insipidus
bedwetting
|
|
gptkbp:bfsParent
|
gptkb:Ferring
gptkb:Ferring_Pharmaceuticals
gptkb:Vasopressin_and_analogues
|
|
gptkbp:bfsLayer
|
7
|